Suzanne Blaug
Director/Board Member chez FIBROGEN, INC.
Fortune : 21 731 $ au 30/04/2024
Profil
Suzanne Blaug is an Independent Director at FibroGen, Inc. She previously worked as Managing Director at Johnson & Johnson, SVP-Global Marketing & Commercial Development at Amgen, Inc., Head at Janssen Alzheimer Immunotherapy, Principal at EMEA Capital LLP, and Vice President-Europe Strategic Marketing at Janssen Global Services LLC.
Blaug holds an undergraduate degree from The University of North Carolina at Chapel Hill and an MBA from Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
FIBROGEN, INC.
0,02% | 31/03/2024 | 21 305 ( 0,02% ) | 21 731 $ | 30/04/2024 |
Postes actifs de Suzanne Blaug
| Sociétés | Poste | Début |
|---|---|---|
| FIBROGEN, INC. | Director/Board Member | 05/06/2019 |
Anciens postes connus de Suzanne Blaug
| Sociétés | Poste | Fin |
|---|---|---|
| AMGEN INC. | Sales & Marketing | 01/08/2018 |
| Janssen Alzheimer Immunotherapy | Corporate Officer/Principal | 01/03/2012 |
Janssen Global Services LLC
 Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The private company is based in Raritan, NJ. | Corporate Officer/Principal | 01/10/2009 |
EMEA Capital LLP
 EMEA Capital LLP Investment ManagersFinance EMEA Capital LLP is a privately-held investment management firm which was founded by Osman Semerci in 2008. Headquartered in London, the firm provides asset management services to individual and institutional clients. | Corporate Officer/Principal | - |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Formation de Suzanne Blaug
| The University of North Carolina at Chapel Hill | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| FIBROGEN, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Janssen Alzheimer Immunotherapy | |
EMEA Capital LLP
EMEA Capital LLP Investment ManagersFinance EMEA Capital LLP is a privately-held investment management firm which was founded by Osman Semerci in 2008. Headquartered in London, the firm provides asset management services to individual and institutional clients. | Finance |
Janssen Global Services LLC
Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The private company is based in Raritan, NJ. | Health Technology |
